CLINICAL_TRIALS ClinicalTrials.gov record update

Biologics in Refractory Vasculitis (BIOVAS): A Pragmatic, Randomised, Double-blind, Placebo-controlled, Modified-crossover Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis in Adults and Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05168475
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:40.793374+00:00
Published At: 2025-06-17T00:00:00+00:00
Record Updated At: 2025-06-17
Results Posted At: 2025-06-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Giant Cell Arteritis", "Takayasu Arteritis", "Cogan Syndrome", "Relapsing Polychondritis", "Cryoglobulinemic Vasculitis", "IgA Vasculitis", "Polyarteritis Nodosa", "Cutaneous Polyarteritis Nodosa", "Primary Angiitis of Central Nervous System"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-17"
protocolSection.identificationModule.nctId: "NCT05168475"
protocolSection.identificationModule.officialTitle: "Biologics in Refractory Vasculitis (BIOVAS): A Pragmatic, Randomised, Double-blind, Placebo-controlled, Modified-crossover Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis in Adults and Children"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-06-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.